Evaluation of HER2 Protein Expression in Gastric Carcinomas: Comparative Analysis of 1414 Cases of Whole-Tissue Sections and 595 Cases of Tissue Microarrays

A study of HER2 gene amplification and protein expression in gastric cancer

(2010) B. Yan et al.   JOURNAL OF CLINICAL PATHOLOGY

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial

(2010) Yung-Jue Bang et al.   LANCET

Targeted HER2 Treatment in Advanced Gastric Cancer

(2010) Jan Trøst Jørgensen   ONCOLOGY

HER2 diagnostics in gastric cancer—guideline validation and development of standardized immunohistochemical testing

(2010) Josef Rüschoff et al.   VIRCHOWS ARCHIV

Association of ERBB2 gene status with histopathological parameters and disease-specific survival in gastric carcinoma patients

(2009) J D Barros-Silva et al.   BRITISH JOURNAL OF CANCER

Development of targeted therapies in advanced gastric cancer: promising exploratory steps in a new era

(2009) Anna D Wagner et al.   CURRENT OPINION IN ONCOLOGY

HER-2 amplification is highly homogenous in gastric cancer

(2009) Andreas H. Marx et al.   HUMAN PATHOLOGY

Updates in Gastrointestinal Oncology – insights from the 2008 44th annual meeting of the American Society of Clinical Oncology

(2009) Milind Javle et al.   Journal of Hematology & Oncology

Comparative Study on Overexpression of HER2/neu and HER3 in Gastric Cancer

(2009) Xiu Li Zhang et al.   WORLD JOURNAL OF SURGERY

HER2 in gastric cancer: a new prognostic factor and a novel therapeutic target

(2008) C. Gravalos et al.   ANNALS OF ONCOLOGY

Assessment of a HER2 scoring system for gastric cancer: results from a validation study

(2008) M Hofmann et al.   HISTOPATHOLOGY